EyePoint Pharmaceuticals

EyePoint PharmaceuticalsEyePoint Pharmaceuticals
EyePoint Pharmaceuticals

EyePoint Pharmaceuticals

Ophthalmology-focused biopharmaceutical company developing sustained-release drug delivery systems for serious eye diseases.

Website
DR 431987InactiveWatertown, United States
Rate
Advertise here

About

EyePoint Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing innovative ophthalmic products for patients with serious eye disorders. Their proprietary Durasert® technology enables sustained intraocular drug delivery, aiming to reduce the frequency of treatments and improve patient outcomes.
Frequently asked

What does EyePoint Pharmaceuticals do?

EyePoint Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing innovative ophthalmic products for patients with serious eye disorders. Their proprietary Durasert® technology enables sustained intraocular drug delivery, aiming to reduce the frequency of treatments and improve patient outcomes.

What is EyePoint Pharmaceuticals's revenue?

StartupHub estimates EyePoint Pharmaceuticals's annual revenue at $36.3M (range $11.4M to $154.2M, 34% confidence), based on comparable companies in the sector.

What is EyePoint Pharmaceuticals's valuation?

StartupHub estimates EyePoint Pharmaceuticals's effective valuation at $9.4M (range $6.2M to $19.8M, 54% confidence), based on comparable companies in the sector.

How much funding has EyePoint Pharmaceuticals raised?

EyePoint Pharmaceuticals has raised a total of $436M in funding. The most recent round on record is Public Offering.

Where is EyePoint Pharmaceuticals headquartered?

EyePoint Pharmaceuticals is headquartered in Watertown, United States.

When was EyePoint Pharmaceuticals founded?

EyePoint Pharmaceuticals was founded in 1987.

What industry does EyePoint Pharmaceuticals operate in?

EyePoint Pharmaceuticals operates in Biotechnology, Biopharmaceuticals, Specialty Pharmaceuticals, Ophthalmology, Drug Delivery Systems, Medical Devices.

What is EyePoint Pharmaceuticals's current status?

EyePoint Pharmaceuticals's current operating status is: Inactive.

New entrants in Biotechnology
Last 90 days
7
New entrants
2.3
Per month
0.5
Per week
Most recent
Galatek

Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.

Jul 13
Raven4batchrecords

Digital batch record software for pharmaceutical and biotech manufacturing.

Jul 9
Trofinetide

Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.

Jun 8
Nanorobotics

A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.

May 28
Matrixcode

MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.

May 27
Cypherpunkcode

A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.

May 26

An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.

Comments

No comments yet. Be the first to share your take.